ADVANCED GASTRIC CARCINOMA
Clinical trials for ADVANCED GASTRIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stomach cancer combo study halted early
Disease control TerminatedThis study tested several drug combinations in 40 people with advanced stomach or gastroesophageal junction cancer that had not been treated before. The goal was to see which combinations shrank tumors. The study was terminated early, so results are limited.
Matched conditions: ADVANCED GASTRIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control TerminatedThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Matched conditions: ADVANCED GASTRIC CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC